Androgen receptor inhibitor–induced “BRCAness” and PARP inhibition are synthetically lethal for castration-resistant prostate cancerLikun Li, Timothy C. Thompson, Xuemei Zuo et al.|Science Signaling|2017Cited by 307
Targeting the MYCN–PARP–DNA Damage Response Pathway in Neuroendocrine Prostate CancerYaoguang Zhang, Timothy C. Thompson, Bo Liu et al.|Clinical Cancer Research|2017Cited by 108
PARP Inhibition Suppresses GR–MYCN–CDK5–RB1–E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate CancerBo Liu, Timothy C. Thompson, Likun Li et al.|Clinical Cancer Research|2019Cited by 78
Table S5-S7 from Targeting the MYCN–PARP–DNA Damage Response Pathway in Neuroendocrine Prostate CancerWei Zhang, Timothy C. Thompson, Bo Liu et al.|Unknown|2023Cited by 0
Table S1 from PARP Inhibition Suppresses GR–MYCN–CDK5–RB1–E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate CancerBo Liu, Timothy C. Thompson, Likun Li et al.|Unknown|2023Cited by 0